237 related articles for article (PubMed ID: 38069266)
1. Identifying Explainable Machine Learning Models and a Novel SFRP2
Yang Z; Zhou D; Huang J
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069266
[TBL] [Abstract][Full Text] [Related]
2. Application of interpretable machine learning algorithms to predict distant metastasis in ovarian clear cell carcinoma.
Guo QH; Xie FC; Zhong FM; Wen W; Zhang XR; Yu XJ; Wang XL; Huang B; Li LP; Wang XZ
Cancer Med; 2024 Apr; 13(7):e7161. PubMed ID: 38613173
[TBL] [Abstract][Full Text] [Related]
3. Application of machine learning techniques for predicting survival in ovarian cancer.
Sorayaie Azar A; Babaei Rikan S; Naemi A; Bagherzadeh Mohasefi J; Pirnejad H; Bagherzadeh Mohasefi M; Wiil UK
BMC Med Inform Decis Mak; 2022 Dec; 22(1):345. PubMed ID: 36585641
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of the Diagnostic Characteristic Genes of Ovarian Cancer by Bioinformatics and Machine Learning.
Liu J; Liu L; Antwi PA; Luo Y; Liang F
Front Genet; 2022; 13():858466. PubMed ID: 35719392
[No Abstract] [Full Text] [Related]
5. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer.
Duan Y; Xu X
Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389
[TBL] [Abstract][Full Text] [Related]
6. Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers.
Kawakami E; Tabata J; Yanaihara N; Ishikawa T; Koseki K; Iida Y; Saito M; Komazaki H; Shapiro JS; Goto C; Akiyama Y; Saito R; Saito M; Takano H; Yamada K; Okamoto A
Clin Cancer Res; 2019 May; 25(10):3006-3015. PubMed ID: 30979733
[TBL] [Abstract][Full Text] [Related]
7. Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status.
Li Y; Nie Y; Guo H; Guo H; Ha C; Li Y
Front Oncol; 2022; 12():847085. PubMed ID: 35372049
[TBL] [Abstract][Full Text] [Related]
8. A Risk Prediction Model for Physical Restraints Among Older Chinese Adults in Long-term Care Facilities: Machine Learning Study.
Wang J; Chen H; Wang H; Liu W; Peng D; Zhao Q; Xiao M
J Med Internet Res; 2023 Apr; 25():e43815. PubMed ID: 37023416
[TBL] [Abstract][Full Text] [Related]
9. The prediction of in-hospital mortality in chronic kidney disease patients with coronary artery disease using machine learning models.
Ye Z; An S; Gao Y; Xie E; Zhao X; Guo Z; Li Y; Shen N; Ren J; Zheng J
Eur J Med Res; 2023 Jan; 28(1):33. PubMed ID: 36653875
[TBL] [Abstract][Full Text] [Related]
10. Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses.
Guo Y; Li S; Li C; Wang L; Ning W
Front Immunol; 2023; 14():1326018. PubMed ID: 38143770
[TBL] [Abstract][Full Text] [Related]
11. Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.
Li MX; Sun XM; Cheng WG; Ruan HJ; Liu K; Chen P; Xu HJ; Gao SG; Feng XS; Qi YJ
BMC Cancer; 2021 Aug; 21(1):906. PubMed ID: 34372798
[TBL] [Abstract][Full Text] [Related]
12. Explainable Machine Learning Model to Prediction EGFR Mutation in Lung Cancer.
Yang R; Xiong X; Wang H; Li W
Front Oncol; 2022; 12():924144. PubMed ID: 35814445
[TBL] [Abstract][Full Text] [Related]
13. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer.
Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P
J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
15. Increased Expression of
Zou R; Xu H; Li F; Wang S; Zhu L
DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
[TBL] [Abstract][Full Text] [Related]
16. Computed tomography-based radiomics machine learning classifiers to differentiate type I and type II epithelial ovarian cancers.
Li J; Li X; Ma J; Wang F; Cui S; Ye Z
Eur Radiol; 2023 Jul; 33(7):5193-5204. PubMed ID: 36515713
[TBL] [Abstract][Full Text] [Related]
17. Explainable artificial intelligence model for identifying COVID-19 gene biomarkers.
Yagin FH; Cicek İB; Alkhateeb A; Yagin B; Colak C; Azzeh M; Akbulut S
Comput Biol Med; 2023 Mar; 154():106619. PubMed ID: 36738712
[TBL] [Abstract][Full Text] [Related]
18. Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced-Stage Ovarian Cancer by Using Machine Learning and Explainable Artificial Intelligence.
Laios A; Kalampokis E; Johnson R; Munot S; Thangavelu A; Hutson R; Broadhead T; Theophilou G; Nugent D; De Jong D
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765924
[TBL] [Abstract][Full Text] [Related]
19. Application of machine learning model in predicting the likelihood of blood transfusion after hip fracture surgery.
Chen X; Pan J; Li Y; Tang R
Aging Clin Exp Res; 2023 Nov; 35(11):2643-2656. PubMed ID: 37733228
[TBL] [Abstract][Full Text] [Related]
20. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
Front Immunol; 2022; 13():943389. PubMed ID: 36003381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
